AI assistant
Sending…
PROKIDNEY CORP. — Director's Dealing 2023
Jan 18, 2023
32485_dirs_2023-01-18_368a9e9d-ca85-4654-804e-4a3c003b4488.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2023-01-16
Reporting Person: Weger Mary (Chief People Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-16 | Employee stock option (right to buy) | $8.43 | A | 185000 | Acquired | 2033-01-16 | Class A Ordinary Shares (185000) | Direct |
Footnotes
F1: The option vests in substantially equal monthly installments over the four year period beginning on January 16, 2023.
More from PROKIDNEY CORP.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 2